Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd C Skaar

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Pharmacogenomics|April 1, 2011
Gene copy number variations: it is important to determine which allele is affectedAnuradha Ramamoorthy, Todd C Skaar
Drug Metabolism Letters|April 5, 2011
In silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genesAnuradha Ramamoorthy, Todd C Skaar
Clinical Pharmacology and Therapeutics|February 24, 2018
CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. FlockhartTodd C Skaar, Zeruesenay Desta
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2013
Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223Eric A Benson, Todd C Skaar
Thrombosis Research|May 11, 2023
Sex specific differences of factor XI and relationship with other coagulation factorsRolf P Kreutz, Joseph Ipe, Todd C Skaar
Frontiers in Pharmacology|January 24, 2020
Nephrotoxicity in a Patient With Inadequate Pain Control: Potential Role of Pharmacogenetic Testing for Cytochrome P450 2D6 and Apolipoprotein L1Emma M Tillman, Todd C Skaar, Michael T Eadon
JCO Precision Oncology|July 25, 2025
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 InhibitorsDarius Meiman, Todd C Skaar, Tyler Shugg, et al.
BMC Genomics|June 24, 2015
A translational bioinformatic approach in identifying and validating an interaction between Vitamin A and CYP19A1Santosh Philips, Jing Zhou, Zhigao Li, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2005
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifenYoung Chai Lim, Zeruesenay Desta, David A Flockhart, et al.
Breast Cancer Research : BCR|January 30, 2008
The role of single nucleotide polymorphisms in breast cancer metastasisJames M Rae, Todd C Skaar, Susan G Hilsenbeck, et al.
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Pharmacogenomics|April 1, 2011
Gene copy number variations: it is important to determine which allele is affectedAnuradha Ramamoorthy, Todd C Skaar
Drug Metabolism Letters|April 5, 2011
In silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genesAnuradha Ramamoorthy, Todd C Skaar
Clinical Pharmacology and Therapeutics|February 24, 2018
CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. FlockhartTodd C Skaar, Zeruesenay Desta
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2013
Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223Eric A Benson, Todd C Skaar
Thrombosis Research|May 11, 2023
Sex specific differences of factor XI and relationship with other coagulation factorsRolf P Kreutz, Joseph Ipe, Todd C Skaar
Frontiers in Pharmacology|January 24, 2020
Nephrotoxicity in a Patient With Inadequate Pain Control: Potential Role of Pharmacogenetic Testing for Cytochrome P450 2D6 and Apolipoprotein L1Emma M Tillman, Todd C Skaar, Michael T Eadon
JCO Precision Oncology|July 25, 2025
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 InhibitorsDarius Meiman, Todd C Skaar, Tyler Shugg, et al.
BMC Genomics|June 24, 2015
A translational bioinformatic approach in identifying and validating an interaction between Vitamin A and CYP19A1Santosh Philips, Jing Zhou, Zhigao Li, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2005
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifenYoung Chai Lim, Zeruesenay Desta, David A Flockhart, et al.
Breast Cancer Research : BCR|January 30, 2008
The role of single nucleotide polymorphisms in breast cancer metastasisJames M Rae, Todd C Skaar, Susan G Hilsenbeck, et al.
Pageof 18